LB

Ligo Bioscience

Catalysing Change in the Chemical Industry

San Francisco, United States · Founded 2024 · $500K raised

Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$500K
Last Round
$500K SeedJan 2024
Rounds
1

About

Ligo Biosciences is a San Francisco-based biotechnology startup building next-generation computational tools to manipulate chemistry and biology, with an initial focus on enzyme design. The company develops deep-learning models that allow scientific agents to search enzyme space deliberately — discovering new catalysts, new biological functions, and novel ways to intervene in biology — and is known for releasing an open-source implementation of AlphaFold3. Ligo's customers and collaborators are researchers and biotech organizations seeking to accelerate chemical manufacturing and biological discovery; their enzyme design tools aim to slash the cost and time of developing new industrial and therapeutic enzymes. Founded in 2024 and backed by Y Combinator, the team spans biology, chemistry, mathematics, and computer science.

Summary

Ligo Bioscience is an Artificial Intelligence company based in San Francisco, United States, founded in 2024. It has raised $500K in total across 1 round, most recently a $500K Seed round in Jan 2024. Investors include Y Combinator Continuity Fund and Soma Capital.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJan 2024
$500K

Investors

Similar Companies